Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
28.00
+0.01
(+0.04%)
Pre-Market: 20:00
Ambrx Biopharma Total Liabilities (Quarterly): 29.10M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 29.10M |
| June 30, 2023 | 29.56M |
| March 31, 2023 | 28.02M |
| December 31, 2022 | 29.13M |
| June 30, 2022 | 38.98M |
| Date | Value |
|---|---|
| December 31, 2021 | 39.05M |
| June 30, 2021 | 20.93M |
| June 30, 2021 | 20.93M |
| December 31, 2020 | 272.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
20.93M
Minimum
Jun 2021
272.17M
Maximum
Dec 2020
56.43M
Average
29.13M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 101.95B |
| Axonics Inc | 88.46M |
| Harpoon Therapeutics Inc (DELISTED) | 43.04M |
| Merck & Co Inc | 65.42B |
| RayzeBio inc (DELISTED) | 28.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 271.50M |
| Shareholders Equity (Quarterly) | 242.40M |
| Current Ratio | 12.80 |